What is the 13F Pro Quality Score for NHC?

13F Pro ranks NATIONAL HEALTHCARE CORP (NHC) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View NHC's current score at https://13fpro.ai/research/NHC (free sign-up required for the full ranking).

Where does 13F Pro source NHC data?

All NATIONAL HEALTHCARE CORP fundamentals and ownership data come directly from SEC EDGAR. NATIONAL HEALTHCARE CORP files with the SEC under CIK 1047335. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is NHC in?

NATIONAL HEALTHCARE CORP (NHC) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is NHC research updated on 13F Pro?

NHC's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

NATIONAL HEALTHCARE CORP(NHC)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSE

Institutional-grade research for retail investors

SEC EDGAR: CIK 1047335 NHC stock profile & AI dashboard →

13F Pro Quality Score

71.2/100

Rank #267 of 2,879 stocksTOP 10%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

76.3/100

Profitability

64.6/100

Balance Sheet

83.3/100

Earnings Quality

81.5/100

Free Cash Flow

70.1/100

Institutional Flow

64.2/100

Revenue Scale

56.9/100

Dilution Risk

82.8/100

NHC Stock Analysis & AI Quality Score

AI stock analysis and institutional research for NATIONAL HEALTHCARE CORP (NHC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NHC at 71.2/100 on a 32-signal composite quality model, placing it at rank #267 of 2,879 stocks — the top 10% of the AI-ranked universe. NHC scores in the top quartile across balance sheet strength (83.3), earnings quality (81.5), revenue growth (76.3). Based on the latest XBRL financial filings (Q1 2026), NATIONAL HEALTHCARE CORP reports quarterly revenue of $381.8M, net income of $35.9M, an operating margin of 8.5%. Top institutional holders of NHC by reported 13-F value include BlackRock,, Morgan Stanley Institutional Investment Advisors, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. NHC trades on the NYSE exchange and files with the SEC under CIK 1047335. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NHC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NATIONAL HEALTHCARE CORP directly from SEC EDGAR. NATIONAL HEALTHCARE CORP's 13F Pro composite quality score has ranged between 8 and 74 since 2021, currently 71.2 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.

✦

Fun facts about NATIONAL HEALTHCARE CORP

Quirks, history, and lore behind NHC — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare services company · small-cap · listed on NYSE American · headquartered in Tennessee.
2
The Numbers
Operates over 70 facilities across more than a dozen states, with annual revenue in the range of roughly $1 billion — steady, unglamorous, essential.
3
The History
Founded in 1971, it grew quietly through the post-Medicare boom era, building a network of long-term care and post-acute facilities across the American South and beyond.
4
The Secret
Its business lives at the intersection of skilled nursing, assisted living, and rehabilitation — the part of healthcare nobody thinks about until grandma needs it.
5
The Lore
Unusually for its size, it has paid dividends consistently for decades and is considered a rare independent operator in a sector dominated by giant chains and private equity roll-ups.
6
The Giveaway
Its three-letter ticker doubles as a shorthand for its full name, and its full name — National Healthcare Corp — is basically the plainest possible description of what it does.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$381.8M

Net Income

Q1 2026

$35.9M

Free Cash Flow

Q1 2026

$52.9M

Operating Margin

Q1 2026

8.5%

D/E Ratio

Q1 2026

0.00

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+41.3% YoY

$1.52BFY 2025

FY19 $996.4MFY20 $1.03BFY21 $1.07BFY25 $1.52B

Net Income

-13.4% YoY

$120.0MFY 2025

FY19 $68.2MFY20 $41.9MFY21 $138.6MFY25 $120.0M

Operating Income

+152.0% YoY

$128.4MFY 2025

FY19 $49.0MFY20 $48.2MFY21 $50.9MFY25 $128.4M

EPS (Diluted)

-14.7% YoY

$7.67FY 2025

FY19 $4.44FY20 $2.72FY21 $8.99FY25 $7.67

Total Assets

+8.8% YoY

$1.53BFY 2025

FY19 $1.29BFY20 $1.36BFY21 $1.40BFY25 $1.53B

Total Debt

$47.5MFY 2025

FY19 $20.0MFY20 $0.00FY21 —FY25 $47.5M

Op. Cash Flow

+196.6% YoY

$185.1MFY 2025

FY19 $100.1MFY20 $203.3MFY21 $62.4MFY25 $185.1M

Metric	FY 2025	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Revenue	$1.52B +41.3%	$1.07B +4.5%	$1.03B +3.2%	$996.4M +1.6%	$980.3M +1.7%	$963.9M
Net Income	$120.0M -13.4%	$138.6M +231.0%	$41.9M -38.6%	$68.2M +15.7%	$59.0M +4.9%	$56.2M
Operating Income	$128.4M +152.0%	$50.9M +5.8%	$48.2M -1.8%	$49.0M -12.6%	$56.1M +3.6%	$54.1M
EPS (Diluted)	$7.67 -14.7%	$8.99 +230.5%	$2.72 -38.7%	$4.44 +14.7%	$3.87 +4.9%	$3.69
Total Assets	$1.53B +8.8%	$1.40B +3.0%	$1.36B +5.9%	$1.29B +19.0%	$1.08B -1.4%	$1.10B
Total Debt	$47.5M	—	$0.00 -100.0%	$20.0M -63.6%	$55.0M -45.0%	$100.0M
Operating Cash Flow	$185.1M +196.6%	$62.4M -69.3%	$203.3M +103.0%	$100.1M +1.7%	$98.4M +4.2%	$94.5M

Get alerted when NHC's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for NATIONAL HEALTHCARE CORP including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of NHC

BlackRock, Inc.
$302.7M1,895,250 sh
Morgan Stanley Institutional Investment Advisors LLC
$165.9M1,038,804 sh
DIMENSIONAL FUND ADVISORS LP
$151.2M946,977 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$126.1M789,421 sh
VANGUARD CAPITAL MANAGEMENT LLC
$87.8M549,548 sh
FIRST TRUST ADVISORS LP
$84.7M530,302 sh
STATE STREET CORP
$78.8M491,575 sh
RENAISSANCE TECHNOLOGIES LLC
$53.6M335,517 sh
GEODE CAPITAL MANAGEMENT, LLC
$51.6M323,267 sh
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$28.5M178,598 sh

Fund	Value	Shares
BlackRock, Inc.	$302.7M	1,895,250
Morgan Stanley Institutional Investment Advisors LLC	$165.9M	1,038,804
DIMENSIONAL FUND ADVISORS LP	$151.2M	946,977
VANGUARD PORTFOLIO MANAGEMENT LLC	$126.1M	789,421
VANGUARD CAPITAL MANAGEMENT LLC	$87.8M	549,548
FIRST TRUST ADVISORS LP	$84.7M	530,302
STATE STREET CORP	$78.8M	491,575
RENAISSANCE TECHNOLOGIES LLC	$53.6M	335,517
GEODE CAPITAL MANAGEMENT, LLC	$51.6M	323,267
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$28.5M	178,598

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put NHC on your watchlist

Track score changes the day NATIONAL HEALTHCARE CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is NHC a good stock to buy?

13F Pro's AI-powered analysis of NATIONAL HEALTHCARE CORP (NHC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NHC are available on the NHC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own NHC?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NHC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NATIONAL HEALTHCARE CORP's investment landscape.